Substitution of marijuana for opioids in a national survey of US adults


Autoři: Julie H. Ishida aff001;  Peggy O. Wong aff002;  Beth E. Cohen aff002;  Marzieh Vali aff002;  Stacey Steigerwald aff002;  Salomeh Keyhani aff002
Působiště autorů: Department of Medicine, Division of Nephrology, San Francisco VA Medical Center, San Francisco, California, United States of America aff001;  Department of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California, United States of America aff002
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article
doi: 10.1371/journal.pone.0222577

Souhrn

Opioid prescriptions for chronic pain and subsequent opioid-related complications have risen dramatically in the US. Recent data suggest that medical marijuana laws have been associated with lower state-level opioid overdose mortality. In a national survey, we examined the prevalence of substitution of marijuana for opioids among US adults taking opioids for pain.Using GfK’s KnowledgePanel, we conducted an Internet-based survey of a nationally representative sample of 16,280 adults in 2017 about individual perceptions and use of marijuana. We developed questions designed to assess the extent and reasons for substitution of marijuana for opioids. We examined opioid substitution among respondents with a history of ever using marijuana who used opioids in the past 12 months. There were 9,003 respondents, corresponding to a 55.3% response rate. The mean age was 48 years. Among the 5% (n = 486) who reported ever using marijuana and using opioids in the past year, 43% used opioids daily, and 23% reported current (past 30 day) marijuana use. Forty-one percent reported a decrease or cessation of opioid use due to marijuana use; 46% reported no change in opioid use; and 8% reported an increase in opioid use. We found that a substantial number of US adults reported that they substituted marijuana for opioids.

Klíčová slova:

Drug users – Opioids – Pain management – Surveys – United States – Marijuana – Opiates – Medical law


Zdroje

1. Reuben D.B., et al., National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain. Ann Intern Med, 2015. 162(4): p. 295–300. doi: 10.7326/M14-2775 25581341

2. Han B., et al., Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med, 2017. 167(5): p. 293–301. doi: 10.7326/M17-0865 28761945

3. Dowell D., Haegerich T.M., and Chou R., CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. Jama, 2016. 315(15): p. 1624–45. doi: 10.1001/jama.2016.1464 26977696

4. Nugent S.M., et al., The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review. Ann Intern Med, 2017. 167(5): p. 319–331. doi: 10.7326/M17-0155 28806817

5. Patel A F.D., Brust JCM, Song S, Miller TR, Narayanswami P., Position Statement: Use of Medical Marijuana for Neurological Disorders. American Academy of Neurology, 2014.

6. Legislatures, N.C.o.S., State Medical Marijuana Laws. 2018.

7. Powell D., Pacula R.L., and Jacobson M., Do medical marijuana laws reduce addictions and deaths related to pain killers? J Health Econ, 2018. 58: p. 29–42. doi: 10.1016/j.jhealeco.2017.12.007 29408153

8. Lucas P. and Walsh Z., Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. Int J Drug Policy, 2017. 42: p. 30–35. doi: 10.1016/j.drugpo.2017.01.011 28189912

9. Vyas M.B., LeBaron V.T., and Gilson A.M., The use of cannabis in response to the opioid crisis: A review of the literature. Nurs Outlook, 2018. 66(1): p. 56–65. doi: 10.1016/j.outlook.2017.08.012 28993073

10. Keyhani S., et al., Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. Ann Intern Med, 2018. 169(5): p. 282–290. doi: 10.7326/M18-0810 30039154

11. Fowler F.J. Jr., Gerstein B.S., and Barry M.J., How patient centered are medical decisions?: Results of a national survey. JAMA Intern Med, 2013. 173(13): p. 1215–21. doi: 10.1001/jamainternmed.2013.6172 23712194

12. Hanauer DA, Z.K., Singer DC, Gebremariam A, Davis MM, Public awareness, perception, and use of online physician rating sites. JAMA Intern Med, 2014(311): p. 7.

13. McAfee T., et al., Effect of the first federally funded US antismoking national media campaign. Lancet, 2013. 382(9909): p. 2003–11. doi: 10.1016/S0140-6736(13)61686-4 24029166

14. Tomlinson T., et al., Moral concerns and the willingness to donate to a research biobank. Jama, 2015. 313(4): p. 417–9. doi: 10.1001/jama.2014.16363 25626040

15. GfK, KnowledgePanel. 2017.

16. Research, A.A.F.P.O., Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 2016.

17. Quality, S.A.a.M.H.S.A.C.f.B.H.S.a., 2017 National Survey on Drug Use and Health: Detailed Tables. 2018.

18. Lucas P., et al., Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug Alcohol Rev, 2016. 35(3): p. 326–33. doi: 10.1111/dar.12323 26364922

19. Lucas P, R.A., Earleywine M, McGowan SK, Oleson M, Coward MP, et al., Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory, 2013. 21(5): p. 435–42.

20. Reiman A., Medical Cannabis Patients: Patient Profiles and Health Care Utilization Patterns. Journal of Evidence-Based Complementary and Alternative Medicine, 2007. 2(1): p. 31–50.

21. Boehnke K.F., Litinas E., and Clauw D.J., Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain, 2016. 17(6): p. 739–44. doi: 10.1016/j.jpain.2016.03.002 27001005

22. Campbell G., et al., Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health, 2018. 3(7): p. e341–e350. doi: 10.1016/S2468-2667(18)30110-5 29976328

23. Abraham A., et al., Media Content Analysis of Marijuana's Health Effects in News Coverage. J Gen Intern Med, 2018. 33(9): p. 1438–1440. doi: 10.1007/s11606-018-4492-9 29845473

24. Steigerwald S., et al., Smoking, Vaping, and Use of Edibles and Other Forms of Marijuana Among U.S. Adults. Ann Intern Med, 2018. 169(12): p. 890–892. doi: 10.7326/M18-1681 30167665


Článek vyšel v časopise

PLOS One


2019 Číslo 10

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Léčba bolesti v ordinaci praktického lékaře
nový kurz
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Revmatoidní artritida: včas a k cíli
Autoři: MUDr. Heřman Mann

Jistoty a nástrahy antikoagulační léčby aneb kardiolog - neurolog - farmakolog - nefrolog - právník diskutují
Autoři: doc. MUDr. Štěpán Havránek, Ph.D., prof. MUDr. Roman Herzig, Ph.D., doc. MUDr. Karel Urbánek, Ph.D., prim. MUDr. Jan Vachek, MUDr. et Mgr. Jolana Těšínová, Ph.D.

Léčba akutní pooperační bolesti
Autoři: doc. MUDr. Jiří Málek, CSc.

Nové antipsychotikum kariprazin v léčbě schizofrenie
Autoři: prof. MUDr. Cyril Höschl, DrSc., FRCPsych.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se